CRISPR gene editing: Industries
Industries
The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
Used by- Universities and colleges Core research tool The tool came from university laboratories and is now used across biology research [1].
- Hospitals and specialty hospital chains Specialist treatment Patients have stem cells collected, receive chemotherapy and have the edited cells returned in specialist centres [3].
- Farmers, dairy co-operatives and fisheries Edited crop varieties Growers can sell gene-edited crops such as Japan's high-GABA tomato, on sale from 2021 [7].
- Innovator pharma and biotech companies new gene-editing medicines Vertex Pharmaceuticals and CRISPR Therapeutics developed Casgevy, the first approved CRISPR medicine [3, 4].
- Health regulators and accreditation bodies New rules Regulators and WHO set new rules for approval and oversight of genome editing [4, 5].
as of 2026-11-11
Sources
- A Tool for Genome Editing: Scientific Background on the Nobel Prize in Chemistry 2020 Royal Swedish Academy of Sciences, 2020
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease US Food and Drug Administration, 2023
- MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia Medicines and Healthcare products Regulatory Agency (GOV.UK), 2023
- WHO issues new recommendations on human genome editing for the advancement of public health World Health Organization, 2021
- Japan Starts Sale of Genome-Edited High-GABA Tomato Institute of Agricultural Sciences for Southern Vietnam (news item crediting Sanatech Seed), 2021